The latest: What they are saying: Importance of intellectual property protections to combat COVID-19
By Tom Wilbur | July 2, 2020
America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
Guest Post: Pride started with protest: Combatting the dual pandemics of COVID-19 and racism this Pride Month
By Guest Contributor | June 30, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
How biopharmaceutical researchers are ensuring COVID-19 vaccines will be safe and effective
By Richard Moscicki, M.D. | June 29, 2020
As the world continues to feel the impact of COVID-19, the biopharmaceutical industry is working around the clock to identify and develop safe and effective vaccines to prevent infection, while...
Read More
Guest Post: Takeda seeks ‘new normal’ for cancer research during the COVID-19 pandemic
By Guest Contributor | June 24, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
In combating COVID-19, science is how we get back to normal
By Lori Reilly | June 24, 2020
America’s biopharmaceutical companies are working around the clock to combat a common enemy: COVID-19. As the fight to research and develop innovative treatments and vaccines advances, I’m pleased...
Read More
Guest post: A post-pandemic crisis: The mental toll on America
By Guest Contributor | June 16, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Stakeholders raise concerns with proposed drastic changes to the pharmaceutical supply chain
By Nicole Longo | June 11, 2020
As we work to combat the current global pandemic, it is especially critical to maintain the stability of our global manufacturing supply chain. Unfortunately, recent policy proposals that would...
Read More
Guest Post: From lab to jab: Vaccine development to prevent COVID-19
By Guest Contributor | June 11, 2020
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
PhRMA awards $100,000 to fund projects that address health inequalities
By Lori Reilly | June 10, 2020
As part of PhRMA’s continuing work to address health inequalities, we are awarding $100,000 total in grants to fund four projects that will help improve health outcomes by addressing inequity in...
Read More
The latest: What they are saying: Intellectual property protections critical as we work to defeat COVID-19
By Tom Wilbur | June 5, 2020
The U.S. biopharmaceutical industry depends on reliable intellectual property (IP) protections to promote the development of new treatments and cures for patients. Strong IP protections are...
Read More
Medicare Monday (100)
340B Spotlight (43)
Cost & Consequence (0)
